Medtronic, Inc. Share Price Monde
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
05-17 | Medtronic Trial for AFib System Achieves Endpoints | DJ |
05-17 | Medtronic Says Small-Diameter Defibrillation Lead Meets Safety, Efficacy Goals in Pivotal Trial | MT |
Sales 2024 * | 32.24B 29.79B 2,538B | Sales 2025 * | 33.57B 31.02B 2,642B | Capitalization | 113B 104B 8,903B |
---|---|---|---|---|---|
Net income 2024 * | 4.56B 4.21B 359B | Net income 2025 * | 5.24B 4.85B 413B | EV / Sales 2024 * | 4.2 x |
Net Debt 2024 * | 22.21B 20.52B 1,748B | Net Debt 2025 * | 21.12B 19.51B 1,662B | EV / Sales 2025 * | 4 x |
P/E ratio 2024 * |
24.3
x | P/E ratio 2025 * |
21
x | Employees | - |
Yield 2024 * |
3.23% | Yield 2025 * |
3.4% | Free-Float | 99.78% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 25/01/15 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 31/05/16 |
Gregory Smith
COO | Chief Operating Officer | 63 | 31/03/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 31/12/12 |
Kendall Powell
BRD | Director/Board Member | 70 | 31/12/06 |
Randall Hogan
BRD | Director/Board Member | 68 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
-6.46% | 179B | |
-3.68% | 67.88B | |
+5.44% | 52.03B | |
+5.70% | 43.3B | |
+4.03% | 41.79B | |
+25.42% | 32.49B | |
+14.00% | 25.65B | |
-4.29% | 24.55B | |
-2.22% | 24.48B |